AZD3632 + Posaconazole

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

AZD3632 + Posaconazole
Treatment and conditionWhere it standsTrials
AZD3632 + Posaconazole for myelodysplastic syndromesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1